Sigrid Therapeutics named by FierceMedTech as one of the "Fierce 15" companies in 2019 – the first Swedish winner ever

Stockholm - March 9, 2020 - Sigrid Therapeutics announced today that the Company has been named by FierceMedTech as one of the 2019 “Fierce 15” companies, one of the most promising private medtech companies in the industry. This is the first time in its eight-year history that a Swedish company has been included on the list.

Sigrid has developed SiPore15, an innovative, non-systemic, medical device based on specially engineered mesoporous silica particles (MSP) that are administered orally and act as "molecular traps" in the gut to capture and block digestive enzymes. This "blocking" results in a reduction in key cardiometabolic risk factors - blood glucose, blood lipids and body fat composition - in both prediabetics and newly diagnosed type 2 diabetics.

"At Sigrid, we work hard to develop and market products that prevent the development of diabetes and obesity. Being named a Fierce 15 company is recognition that our medical device therapeutic product can help achieve that goal," says Sigrid CEO and co-founder Sana Alajmovic. "By leveraging complex materials technology to create an easy-to-use, safe and affordable solution for people at risk of disease, we are committed to halting the global rise in chronic diseases, one of the greatest health threats of our time."

The Fierce 15 celebrates the spirit of being “fierce” – with innovation and creativity, even in the face of fierce competition. This is FierceMedTech’s 8th annual Fierce 15 nomination. This year’s full list can be viewed at: https://www.fiercebiotech.com/special-report/fiercemedtech-s-2019-fierce-15 .

“One of the real joys of following this field is being able to talk to the people driving the next big medical advances—technologies that may not only change the lives of a patient or parent, but also the daily work of clinicians, surgeons, researchers, and the developers themselves,” says Conor Hale, associate editor at FierceMedTech. “Potential breakthroughs like these could lead to new therapies, procedures, and programs, and ultimately more curative treatments for more people.”

FierceMedTech is an internationally recognized industry media outlet with daily reports reaching a network of over 90,000 medical device industry professionals, providing subscribers with insider analysis of the day's top news stories. Each year, FierceMedTech evaluates hundreds of private companies from around the world for its annual Fierce 15 list. The selection is based on a variety of factors including the strength of the technology platform, partnerships, investor base and competitive market position.